Welcome to the February edition of the WCN’22 Pre-Congress Newsletter:
A preview of the top science, events, and networking coming to you this month. |
| Access WCN'22 accredited content available for a single registration fee. |
|
|
 |
Scientific Articles
|
|
 |
Speaker Interview
|
Sustainable Kidney Care is the ‘Green’ Choice for the World
|
In her Hugh de Wardener lecture at WCN’22, Dr. Frances Mortimer, medical director of the Centre for Sustainable Healthcare in Oxford (UK), will explain what is meant by “sustainable healthcare” and what can be done to achieve it. She will underline why sustainable healthcare is important for health conditions, especially kidney health, as well as the environment. |
| “Human health is dependent on healthy ecosystems for the absolute fundamentals: clean air, food, water, shelter, and freedom from violence, for example, from conflict over scarce resources and migration. Currently, all of these are threatened by the global ecological crisis resulting from human activities,” says Dr. Mortimer. |
|
|
|
 |
Featured Talk
|
Shared Decision-making in Treating Chronic Kidney Disease
|
As a strong advocate for patient-oriented research, patient engagement, and integrated knowledge translation, Dr. Brenda Hemmelgarn, dean of the Faculty of Medicine and Dentistry at the University of Alberta, Canada, focuses on using administrative data to improve care and outcomes for patients with kidney disease and other chronic conditions. |
| In her talk at WCN’22, Dr. Hemmelgarn will discuss her recent work on developing a new CKD clinical care pathway for primary care providers. |
|
|
|
 |
Featured Talk
|
Setting up Successful Urgent-start Peritoneal Dialysis Programs
|
Dr. Esther Tan Zhao Zhi is a consultant nephrologist at the Selayang Hospital near Kuala Lumpur in Malaysia. In her talk at WCN’22, she will discuss how urgent-start peritoneal dialysis (USPD) programs work and the key elements for their success. |
| Peritoneal dialysis (PD) is greatly under-utilized in most parts of the world, despite being preferred by many nephrologists and patients. Various factors, including late end-stage referrals and urgent kidney replacement therapy, mean that PD may not be considered a treatment option. But new techniques for USPD treatment allow for initiation within days. |
|
|
|
 |
Featured Talk
|
Hunting for Genetic Causes of Kidney Disease in Asia
|
Dr. Kar Hui Ng is a pediatric nephrologist in the National University Health System in Singapore and an associate professor at the National University of Singapore, where she studies the genetics of kidney diseases in children. |
| In her talk at WNC’22, Dr. Ng will discuss the collagen IV genes that cause Alport syndrome and their unexpected higher prevalence among her Asian cohort. |
|
|
|
 |
Featured Talk
|
Searching for Genetic Markers for Inflammation and Fibrosis in Kidney Disease
|
Dr. Katalin Susztak is a professor of medicine and genetics at the University of Pennsylvania, USA. She is a physician-scientist investigating the genetic and molecular mechanism of kidney disease development, with the ultimate goal of finding new, more effective therapies. |
| In her talk at WCN’22, Professor Susztak will discuss her research to identify a defect in mitochondrial integrity and function that can lead to the development of kidney disease in animal models and patients and could offer a new therapeutic pathway for patients with CKD. |
|
|
|
|
 |
Featured Talk
|
Aiming for Improvements in Kidney Function Testing
|
Dr. Lydia Kamaruzaman is a nephrologist at the Hospital Canselor Tuanku Muhriz in Kuala Lumpur, Malaysia, and the National University of Malaysia. In her talk at WCN’22, she will discuss the biomarkers available to estimate glomerular filtration rate (eGFR) and potential estimating equations and their limitations. |
| Dr. Kamaruzaman explains: “The most common marker used to estimate GFR is creatinine, a by-product of muscle metabolism. But because muscle mass varies, the serum concentration of creatinine may differ between individuals with the same level of kidney function.” |
|
|
|
|
|
 |
CME Accreditation
|
| The ISN World Congress of Nephrology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 18 European CME credits (ECMEC®s). |
| |
|
 |
 |
WCN Features
|
| Pre-Congress Courses |
WCN’22 provides an outstanding opportunity to learn new skills or refresh existing ones at one of seven pre-congress courses available on the virtual congress platform. |
| Raising-the-Curtain Sessions |
From February 21-22, 2022, ISN Collective-Member Societies and Regional Societies will join us for a series of inspiring Raising-the-Curtain sessions. |
|
| Industry Symposia and Showcase |
We invite you to visit the exhibitors at our Industry Showcase - WCN's virtual exhibition area. |
| ISN Community Film Event |
Thanks to all who submitted to the 2022 ISN Community Film Event. A jury is now selecting finalists from among 22 films received. Vote for your favorite by Saturday, February 26, 2022 at midnight MYT! |
| Networking |
The chance to connect and exchange with delegates worldwide - seeing old friends and meeting new people - is at the heart of the WCN’22 event. |
Join us on our special networking platform for short
Topical Networking events - view the schedule here. |
|
|
|
 |
|
 |
 |
INDUSTRY SYMPOSIA
|
Industry symposia, presented by leading experts, offer pertinent data on the latest scientific information and developments from industry. Industry symposia are not organized by ISN and are not accredited with CME through WCN. Organizers may offer separate accreditation for their sessions. Visit the Industry Showcase for information on and interaction with industry representatives. |
| Friday, February 25, 2022 |
| Sanofi: Vascular Calcification in CKD - The Hidden Threat |
| Zydus Cadila: HIF-PH Inhibitors - a Novel Option for Anemia Management-Expectations and Potential Concerns |
| Baxter: Rise of Baxter’s Advanced Therapies |
| Novartis: A Focus on IgAN - Evolving Challenges and Therapeutic Advances |
| Fresenius Medical Care: Water Quality for Hemodialysis: An Urgent Need in Developing Economies to Ensure Patient Safety |
| AstraZeneca: The Evidence-based CKD Clinic: Changing Practice with SGLT2 Inhibition |
| Excel Continuing Education: Shortening the Path to an aTTP Diagnosis in the Nephrology Clinical Setting |
| GSK: PROs in Practice: How and Why You Should Consider Adding Patient-reported Outcomes to Your Routine CKD Care |
| Calliditas Therapeutics: Looking Upstream in IgAN: The Role of the Gut and Its Implications |
| Chinook Therapeutics: New Frontiers in the Treatment of Glomerular Diseases |
|
Saturday, February 26, 2022 |
| Baxter: What has COVID Taught Us & How Does the Future Look Like |
| Kyowa Kirin: Dialysis Treatment Trends from a Global Perspective |
| AstraZeneca: Bending the Curve of CKD Medicine with SGLT2i |
| Sanofi: Application of Genetics in the Care of Kidney Patients |
| Nipro Asia: Super High Flux Dialyzer and Mortality in Hemodialysis Patient |
| Bayer: Non-steroidal MRAs: Expanding the Evidence-base in CKD and T2D and Exploring New Opportunities |
| Travere Therapeutics : The Link Between Endothelin-1, Angiotensin II, and Proteinuria in the Pathophysiology of CKD |
| Otsuka / Visterra: The International Patient and Provider Voice in IgA Nephropathy |
| Novartis: Addressing the Unmet Needs in Complement-mediated Kidney Diseases |
| AstraZeneca: Controversies in Hyperkalaemia Management and Practical Approaches |
| Boehringer Ingelheim & Lilly Alliance: A Discussion with KDIGO: Advancing Evidence-Based Care in Diabetes and CKD |
|
Sunday, February 27, 2022 |
| Abbott: Relationship Between Blood Pressure Control and Treatment Adherence Among Your Hypertensive Patients |
|
|
|
|
 |
 |
Social Media
|
#ISNWCN SOCIAL MEDIA TEAM INTERVIEWS
|
#ISNWCN Interview:
Dr. Gireesh Siddaiah in conversation with ISN President, Prof. Agnes Fogo
|
|
#ISNWCN Interview:
Fernanda Arce in conversation with KI Editor in Chief, Prof. Pierre Ronco
|
| All interviews can be found here. |
|
SOCIAL MEDIA WALL AND OFFICIAL HASHTAG
|
| We want to hear from you before, during, and after WCN’22! Post on WCN and share your pictures and messages on social platforms: Twitter, Instagram, Facebook, and LinkedIn. By using hashtag #ISNWCN, your posts will feature on the WCN’22 social media wall. Start sharing now. |
| |
|
 |
 |
YOUNG NEPHROLOGISTS
|
CONNECT AND GET INVOLVED: ISN YOUNG NEPHROLOGISTS AT WCN’22
|

The Young Nephrologists Committee’s (YNC) virtual gathering will take place on Saturday, February 26 at 4:30 p.m. MYT (convert to your time zone here).This is your chance to catch up with colleagues and meet new people! |
| The YNC will host a session during the main congress program on Friday, February 25, at 6 p.m. MYT, “The Future is Bright: Young Nephrologists in Action” which will highlight the achievements of young nephrologists from across the world, discuss the impact of COVID-19 on young nephrologists’ training as well as their leadership roles in the development of peritoneal dialysis services across the world. The session will be moderated by YNC Chair and Co-Chair, Dr. Marine Wainstein and Dr. Sabine Karam. |
| The session will end with presentations from the recipients of the 2022 Young Nephrolgists Awards for WCN best clinical and basic science research abstracts, Dr. Jiao Yuanyuan and Dr. Philip McCown. |
| |
|
 |
| |
Thank you to our premium supporters
|
Platinum Support
|
|
|
|
Gold Support
|
|
|
|
Silver Support
|
|
|
|
|